Potential of Immune-Related Therapy in COVID-19
At the beginning of 2020, a sudden outbreak of new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), infections led to anxiety, panic, and crisis among people worldwide. The outbreak first occurred in Wuhan, China, in late December 2019 and then spread rapidly across the glo...
Main Authors: | Chunjue Yuan, Ruoyun Li, Guohong Liu, Yunbao Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.609212/full |
Similar Items
-
Convalescent plasma treatment is associated with lower mortality and better outcomes in high-risk COVID-19 patients – propensity-score matched case-control study
by: Adam Tworek, et al.
Published: (2021-04-01) -
A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report
by: Hongbing Peng, et al.
Published: (2020-07-01) -
Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives
by: Sabna Kotta, et al.
Published: (2020-11-01) -
Emerging Prevention and Treatment Strategies to Control COVID-19
by: Vipul K. Singh, et al.
Published: (2020-06-01) -
The Three Pillars of COVID-19 Convalescent Plasma Therapy
by: Massimo Franchini, et al.
Published: (2021-04-01)